Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 504 of 5804
-
New antitoxin aims to speed kidney recovery in kids with e. coli infection
Disease control Recruiting nowThe objectives of this study are to evaluate the efficacy, safety, and pharmacokinetics of INM004 in pediatric patients with Hemolytic Uremic Syndrome associated to infection by Shiga toxin-producing Escherichia coli (STEC-HUS).
Phase: PHASE3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Engineered immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis is an open-label phase I study to determine the safety and recommended phase 2 dose (RP2D) of Senza5 CART5 cells in patients with relapsed or refractory CD5 positive nodal T cell NHL. RP2D will be based on the safety, tolerability, pharmacokinetics, and preliminary efficacy …
Phase: PHASE1 • Sponsor: Vittoria Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug aims to reduce deaths from severe lung failure
Disease control Recruiting nowBTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections.…
Phase: PHASE2 • Sponsor: BioAegis Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sound waves to zap hypertension? new trial tests ultrasound treatment
Disease control Recruiting nowThe primary objective of the THRIVE Pivotal study is to demonstrate the adjunctive effectiveness and the safety of the TIVUS system in: 1. subjects with uncontrolled hypertension (HTN) receiving 0 - 2 anti-hypertensive drugs of different classes in whom the anti-hypertensive med…
Phase: NA • Sponsor: SoniVie Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of this clinical trial is to learn if allogeneic cord blood-derived CAR-T cell drug works to treat Multiple Myeloma (MM) including Bone-related extramedullary (EMB) disease and extramedullary extraosseous disease(EME) in adults. It will also learn about the safety of …
Phase: PHASE1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug targets tough cancers in early trial
Disease control Recruiting nowThe goal of this YH42946-101 is to evaluate the safety, Tolerability, Pharmacokinetics and anti-tumor activity of YH42946 in patients with locally advanced of metastatic solid tumors with HER2 aberration and EGFR exon 20 insertions.
Phase: PHASE1, PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Wrist-Worn nerve stimulator aims to tame atrial fibrillation after ablation
Disease control OngoingDetermine the role of vagal/median nerve stimulation using the CardiaCare RR2 home care wearable neuromodulation system on suppressing atrial arrhythmias and related symptoms in patients who have undergone AF ablation. The study population will be comprised of adults (age ≥18 yrs…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Heart study aims to find best treatment for minorities with clogged arteries
Disease control Recruiting nowThis is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The…
Phase: PHASE3 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Custom DNA vaccine targets Kids' brain tumors in early trial
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with central nervous system tumors that have returned or have been resistant to treatment.
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:30 UTC
-
New pill hopes to slow rare brain disease MSA
Disease control Recruiting nowThe primary objective of the study is to evaluate the efficacy of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the study is to evaluate specific efficacy parameters of TEV-56286. Another secon…
Phase: PHASE2 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a gut zapping procedure free diabetics from insulin?
Disease control OngoingThe purpose of this study is to determine whether RFVA of the duodenal mucosa with or without the combination of Semaglutide is a safe and effective treatment to remove the need for insulin therapy among patients with T2D who are on stable doses of insulin.
Phase: NA • Sponsor: Aqua Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New cocktail of four drugs hopes to fight Hard-to-Treat bile duct cancer
Disease control Recruiting nowThis is a multicenter Phase 1b/2 clinical trial investigating the efficacy and safety of a combination regimen of Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab in treatment-naïve patients with unresectable, locally advanced, or metastatic biliary tract cancers (BTC), i…
Sponsor: CHA University • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
Spinal shock therapy: new device aims to restore bladder function in paralyzed veterans
Disease control Recruiting nowThe investigators are looking to determine the safety and efficacy of non-invasive transcutaneous spinal cord stimulation (TSCS) in promoting recovery of lower urinary tract (LUT), bowel, sexual, and cardiovascular function, as well as spasticity in individuals with subacute and …
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Emergency rooms could be key to ending HIV: new study tests simple PrEP strategies
Prevention OngoingSevere inequities in HIV pre-exposure prophylaxis (PrEP) access and use in communities hardest hit by the HIV epidemic persist, further exacerbating ongoing racial/ethnic and socioeconomic disparities in HIV incidence. In these same communities, many patients at risk for HIV seek…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Could an arthritis drug shrink dangerous brain aneurysms?
Disease control Recruiting nowPatients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for …
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New MRI scan could predict pancreatic cancer treatment success
Diagnosis Recruiting nowThis study evaluates an investigational scan called hyperpolarized carbon-13 pyruvate magnetic resonance imaging (MRI) in assessing treatment response in patients with pancreatic ductal carcinoma (PDA) that has spread to nearby tissue or lymph nodes (locally advanced) or that has…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New combo therapy offers hope for cancer patients who Can't breathe
Disease control Recruiting nowThis phase I/II trial studies the side effects of interstitial photodynamic therapy following palliative radiotherapy and how well it works in treating patients with inoperable malignant central airway obstruction. Patients who have advanced stage cancer tumors in the lung can of…
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New weekly shot helps shed pounds in obesity trial
Disease control CompletedA Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 compared with placebo, given once a week as subcutaneous injection for 36 weeks, in male and female participants of at least 18 years of age who are living …
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Common antifungal drug shows promise against esophageal cancer
Disease control Recruiting nowEsophageal cancer, which has a low 5-year overall survival rate (\<20%) is increasing in incidence. Previous studies have shown that Hedgehog, AKT, and angiogenic signaling pathways are activated in a significant number of esophageal cancers. Itraconazole, a widely used anti-fung…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for diabetic nerve pain: phase 3 trial launches
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC